// App-Quantinova.ai

: Comparison of Efficacy and Safety of Biosimilar CT-P10 to Rituximab in Patients with Previously Untreated Low Tumor Burden Follicular Lymphoma (LTBFL): A Randomized Phase III Study

Researchers

Presenter

  • Michinori Ogura

Principal Investigators

  • Seok-Goo Cho

  • Hideyuki Nakazawa

  • Junji Suzumiya

  • Gayane Tumyan

  • Jin Seok Kim

  • Anne Lennard

  • Jose Mario Mariz

  • Nikolai Ilyin

  • Wojciech Jurczak

  • Aurelio Lopez Martinez

  • Olga Samoilova

  • Edvard Zhavrid

  • Eduardo Yanez Ruiz

  • Marek Trneny

  • Leslie Popplewell

  • Bertrand Coiffier

  • Christian Buske

  • Won Seog Kim

  • SangJoon Lee

  • Sungyoung Lee

  • YunJu Bae

  • Larry W Kwak

Medical Centers

  • Department of Hematology and Oncology, Kasugai Municipal Hospital, Konan, Japan

  • Pathology Department. Hospital Germans Trias i Pujol, Badalona, Spain

  • Department of Hematology, Leukemia Research Institute, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)

  • Department of Radiology, Shinshu University School of Medicine, Matsumoto, Japan

  • Innovative Cancer Center/Oncology-Hematology, Shimane University Hospital, Izumo, Japan

  • Department of Chemotherapy of Hemoblastosis,Blokhin Russian Cancer Research Center,Moscow,Russ

  • Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea, Republic of.

  • Northern Institute for Cancer Research Newcastle University, Newcastle, United Kingdom

  • Hematology, Istituto Portugues de Oncologi IPO, Porto, Portugal

  • Russian Research Center for Radiology and Surgical Technologies, Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

  • Department of Hematology, Jagiellonian University Hospital, Krakow, Poland

  • Hospital Arnau Vilanova, Valencia, Spain

  • Nizhnii Novgorod Regional Clinical Hospital, Nizhnii Novgorod, Russia

  • N.N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology, Minsk, Belarus

  • Universidad de La Frontera, Temuco, Chile.

  • Dept. of Hematology, Charles University General Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic

  • Department of Hematology and Hematopietic Cell Transplantation, City of Hope, Duarte, CA

  • Pediatric Radiology Unit - Hospices Civils de Lyon, Lyon, France

  • Institute for Experimental Cancer Research, Comprehensive Cancer Center Ulm, Ulm, Germany

  • Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

  • Clinical Development Division, Celltrion, Inc., Incheon, Korea, Republic of (South)

  • Toni Stephenson Lymphoma Center and Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope, Duarte, CA

Locations

  • Japan

  • Spain

  • Republic of South Korea

  • Russia

  • United Kingdom

  • Portugal

  • Poland

  • Belarus

  • Chile

  • Czech Republic

  • United States

  • France

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Follicular lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • Rituximab

  • CT-P10

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • NCT02260804

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved